Filing Details
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2009-04-13 11:53:15
- Reporting Period:
- 2009-04-08
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882104 | Pdl Biopharma Inc. | PDLI | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1191251 | W Paul Sandman | C/O Pdl Biopharma, Inc. 932 Southwood Blvd Incline Village NV 89451 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2009-04-08 | 10,000 | $7.38 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
